Freenome, an early cancer detection company developing blood-based tests to identify cancer at its most treatable stage, ...

Guam Memorial Hospital Authority said it received recertification of its respiratory services under the Clinical Laboratory Improvement Amendments, CLIA, program, administered under the Centers for ...

As more home-based care providers rely on AI tools for both clinical advancements and operational streamlining, the ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter of ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa(TM) Lymphoma test ...

In this GEN webinar, experts from Sampled and Rady Children’s Hospital will discuss the validation and clinical integration ...

The developer of a blood-based breast cancer assay, BCAL Diagnostics (ASX:BDX) has scored the trifecta by acquiring the local ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, today announced it has been ...

Revvity, Inc. (NYSE: RVTY) today announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi (EURONEXT: SAN ...

Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP ...

This achievement marks the company's second CLIA certification in 2025, following its San Diego facility earlier this year, underscoring Crown Bioscience's continued commitment to expanding its global ...